Fig. 5From: Prognostic significance of blood-based PD-L1 analysis in patients with non-small cell lung cancer undergoing immune checkpoint inhibitor therapy: a systematic review and meta-analysisSubgroup analysis of PD-L1 expression in CTCs versus OS/ PFS after different treatment durationsBack to article page